Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1739806

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1739806

Oligonucleotide Synthesis Market,By Equipment and Services, By Technology, By Nucleic Acid, By Application, By End User, By Geography

PUBLISHED:
PAGES: 198 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Oligonucleotide Synthesis Market is estimated to be valued at USD 4.69 Bn in 2025 and is expected to reach USD 9.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.69 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.90% 2032 Value Projection: USD 9.68 Bn

Oligonucleotides are commonly used as primers for polymerase chain reaction (PCR), PCR assays, and panels for biologically related genes. Antisense oligonucleotides are used to reduce levels of protein synthesis by inhibiting mRNA processing or translation. Other uses of oligonucleotides include DNA sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), and nucleic acid aptamers. Moreover, many pharmaceutical companies are focusing on developing nucleic acid-based therapeutics due to which the demand of oligonucleotide is increasing. Hence, market players are focusing on expanding their manufacturing facilities, which is expected to boost the market growth over the forecast period. For instance, in August 2020, Agilent Technologies Inc., announced the expansion of its state-of-the-art production facility in Frederick, Colorado, which develops manufactures oligos that hold potential to be used as treatments for diseases such as COVID-19, cardiovascular disease, cancer, rare and infectious diseases, and other conditions.

Market Dynamics:

Key players are focusing on various inorganic growth strategies such as collaborations, partnerships and agreements, which is expected to propel the growth of the global oligonucleotide synthesis market during the forecast period. For instance, on August 05, 2020, Evotec SE, a drug discovery and development company entered into a strategic partnership with Secarna Pharmaceuticals GmbH & Co. KG, a drug discovery company, for the development of antisense oligonucleotide therapies.

Moreover, in November 2019, CSBio, a peptide and instrumentation manufacturing company entered into a collaboration with Sunresin, a supplier of ion exchange resin and absorption & separation resin for the development of an optimized polystyrene resin for commercial scale oligonucleotide synthesis.

Key features of the study:

  • This report provides in-depth analysis of the global oligonucleotide synthesis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global oligonucleotide synthesis market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Sigma-Aldrich Corporation, GE Healthcare, Integrated DNA Technologies, Inc., TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, Shanghai SynTheAll Pharmaceutical Co., CUSABIO Technology LLC, Synbio Technologies, GENEWIZ, Eurofins Scientific, Agilent Technologies, Kaneka Eurogentec S.A., and LGC, Biosearch Technologies
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, market expansion, and marketing tactics
  • The global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market.

Detailed Segmentation:

  • Global Oligonucleotide Synthesis Market, By Equipment & Services:
    • Equipment/Synthesizer
    • Reagents
    • Services
    • Oligo Synthesis
    • Modification
    • Purification
  • Global Oligonucleotide Synthesis Market, By Technology:
    • Column-based
    • Microarray-based
  • Global Oligonucleotide Synthesis Market, By Nucleic Acid Type:
    • DNA
    • RNA
  • Global Oligonucleotide Synthesis Market, By Application:
    • Drug Discovery
    • Therapeutics
  • Global Oligonucleotide Synthesis Market, By End User:
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical-Biotechnology Companies
  • Global Oligonucleotide Synthesis Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific
    • Sigma-Aldrich Corporation
    • GE Healthcare
    • Integrated DNA Technologies, Inc.
    • TriLink BioTechnologies, Inc
    • BioAutomation Corporation
    • Twist Bioscience
    • Shanghai SynTheAll Pharmaceutical Co.
    • CUSABIO Technology LLC
    • Synbio Technologies
    • GENEWIZ
    • Eurofins Scientific
    • Agilent Technologies
    • Kaneka Eurogentec S.A.
    • LGC, Biosearch Technologies
Product Code: CMI4257

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Equipment and Services
    • Market Snippet, By Technology
    • Market Snippet, By Nucleic Acid
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Oligonucleotide Synthesis Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Oligonucleotide Synthesis Market, By Equipment and Services, 2020- 2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Equipment and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends
  • Nucleic Acid Synthesizer
  • Peptide Synthesizer
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends
  • Oligo Synthesis
  • Modification
  • Purification

6. Global Oligonucleotide Synthesis Market, By Technology, 2020 - 2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • ColuBn-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends
  • Microarray-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends

7. Global Oligonucleotide Synthesis Market, By Nucleic Acid, 2020 - 2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • DNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends
  • RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends

8. Global Oligonucleotide Synthesis Market, By Application, 2020 - 2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends

9. Global Oligonucleotide Synthesis Market, By End User, 2020 - 2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Academic Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends
  • Pharmaceutical-biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
    • Segment Trends

10. Global Oligonucleotide Synthesis Market, By Region, 2020 - 2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2020 -2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2020 -2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Merck KGaA
    • Danaher Corporation
    • Twist Bioscience
    • STA Pharmaceutical Co. Ltd.
    • KINOVATE LIFE SCIENCES
    • CUSABIO TECHNOLOGY LLC
    • Synbio Technologies
    • GENEWIZ
    • Agilent Technologies, Inc.
    • Maravai LifeSciences Holdings, Inc.
    • Biogen
    • Eurofins Scientific
    • Sarepta Therapeutics, Inc.
    • LGC Limited
    • Kaneka Corporation
    • Biotage
    • Nitto Denko Corporation

12. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!